AXL and neoplasm: Four of 13 overlapped markers (MXRA8, CLMP, VCAN and FBLN1) are involved in cell adhesion and tumor metastasis (28–33), suggesting that dysfunctions in cell adhesion pathways could lead to anti-PD-1 resistance associated by RIPK1 and AXL.